(Boursier.com) — The biotechnology company Pherecydes Pharma announces that the Commercial Court of Lyon has dismissed Akkadian’s request to postpone the vote on the merger with Erytech Pharma.
Pherecydes Pharma and Erytech “welcome the interim order issued today by the President of the Commercial Court of Lyon”. The latter has indeed rejected the attempt by Akkadian Partners to obtain the postponement of the vote on the merger.
Consequently, the shareholders of Pherecydes Pharma and Erytech will be able to validly decide on the merger on June 23.
An expert has been appointed to examine the merger parity and will have to submit his report to the parties within 4 months.
This expertise will be carried out at the expense of Akkadian Partners, which has also been ordered to compensate Pherecydes Pharma and Erytech for the costs that the company has incurred in the context of the procedure.
©2023 Boursier.com